| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7aecd37740bde551041fdfe76a17ba38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7863ed8067543a8bf5a09ca3757830ae |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-20 |
| filingDate |
2011-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02ff456d962b481ed37ab7e9081213ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c0856e405d9f2eed05c3506b0ec5c36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18348dacf304493282818cb2283ff8b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7008e38c2b9f66f8a7c779024b921ad4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13617a6de32642b2c13bea5724ca736b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2174625c6eab282959421833f1a94e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c7e9e6e0e7c4150dac74170d99e59c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c1c4394abf3948ef8ca05b24e9315d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2de36577004b63323f966fa21ab8f36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67a0312d2f041fb121b1ed724e8909f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_863b85d1871a62579bf15b5517819e13 |
| publicationDate |
2013-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-102286091-B |
| titleOfInvention |
Solid phase synthesis process of thymosin alpha1 |
| abstract |
The invention relates to a solid phase synthesis process of thymosin alpha1. The process comprises the following steps of: (1) preparation of NH2-Asn(Trt)-CTC resin; (2) synthesis of AA(1-27)-Asn(Trt)28-CTC resin; (3) preparation of Ac-AA(1-27)-Asn28(Trt)-CTC resin; (4) preparation of crude thymosin alpha1 by using a cracking agent; and (5) purification of the crude thymosin alpha1. |
| priorityDate |
2011-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |